A detailed history of Baker Chad R transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baker Chad R holds 21,700 shares of MRK stock, worth $2.15 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
21,700
Previous 21,700 -0.0%
Holding current value
$2.15 Million
Previous $2.69 Million 8.27%
% of portfolio
0.5%
Previous 0.57%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$70.31 - $77.77 $624,141 - $690,364
-8,877 Reduced 29.03%
21,700 $1.69 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $795,642 - $882,999
-11,086 Reduced 26.61%
30,577 $2.5 Million
Q3 2020

Nov 09, 2020

SELL
$73.18 - $82.95 $2,707 - $3,069
-37 Reduced 0.09%
41,663 $3.46 Million
Q1 2020

May 01, 2020

SELL
$63.36 - $87.82 $1.27 Million - $1.76 Million
-20,000 Reduced 32.41%
41,700 $3.21 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $898,680 - $1.04 Million
-13,775 Reduced 18.25%
61,700 $4.71 Million
Q2 2017

Aug 14, 2017

BUY
N/A
75,475
75,475 $4.84 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Baker Chad R Portfolio

Follow Baker Chad R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

News

Stay updated on Baker Chad R with notifications on news.